The Policlinico of Milan also known as Ospedale Maggiore di Milano or Ca' Granda Ospedale Maggiore Policlinico, is one of the oldest hospitals in Italy, founded by Duke Francesco Sforza in 1456. Today it is a modern hospital with 900 beds, with wards for adults, pregnant women and children.

There are 900 beds in UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.

During the past decade, UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" are "COVID-19" (2 trials). Many other conditions were trialed in "UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" in a lesser frequency.

Most popular intervention types in "UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Remdesivir" (2 trials) and "Standard of Care" (2 trials). Other intervention names were less common.

The vast majority of trials in "UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".